Skip Navigation and Go To Content

Office of Technology Management

pictureindex

Office of Technology Management
University Center Tower (UCT)
7000 Fannin Street, Suite 1400
Houston, Texas 77030
Phone: (+1) 713-500-3369    
Fax: (+1) 713-500-0331
Email: otm@uth.tmc.edu


Latest Technologies

Method for Matrix Computation with Homomorphic Encryption

­Researchers have developed a general method based on homomorphic encryption for performing computations on sensitive data while guaranteeing privacy. More specifically, this secure matrix operation framework can protect data privacy or trade secret that have a sensitive nature, and have potential applications in Healthcare IT and Financial Section. Background Homomorphic encryption is a powerful method that allows computations to be performed on data without decrypting it and without access to a private key. Typically, sensitive information (such as genomic data) is stored in an encryp...

Intra-operatively Fitted Antibiotic Spacer Construct for Periprosthetic Joint Infection (PJI) Treatment

­Researchers at UTHealth have created a novel antibiotic spacer to address the known limitations of contemporary antibiotic spacers for PJI treatment while concurrently preserving the functionality of existing devices. The newly designed intra-operatively shapeable antibiotic spacer construct is incorporated with additional capabilities to treat bone defects while preserving host bone and has the potential to significantly impact the manner in which surgeons treat PJI. Technology Overview PJI is an uncommon but one of the most devastating complications following total joint replacement t...

LGR4 Specific Monoclonal Antibodies and Their Use

­Researchers at UTHealth have isolated and characterized monoclonal antibodies as well as antibody fragments that specifically binding to LGR4, a 7TM receptor that is highly expressed in major types of solid tumors, including but not limited to colorectal cancer, non-small cell lung cancer, and ovarian cancer. These LGR4 specific monoclonal antibodies have the potential applications for cancer therapeutics, diagnosis and detection. Background Leucine-rich repeat-containing, G-protein coupled receptor 4 (LGR4) consists of a large extracellular domain with 17 leucine-rich repeats and a se...

See All Available Technologies...

Follow OTM on Social Media:

twitter logo rounded corners   linked in logo rounded corners

News & Events Archive